» Articles » PMID: 24407938

The Relationship of State Medicaid Coverage to Medicaid Acceptance Among Substance Abuse Providers in the United States

Overview
Publisher Springer
Specialty Health Services
Date 2014 Jan 11
PMID 24407938
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

The Affordable Care Act will dramatically increase the number of Americans with Medicaid coverage for substance abuse treatment (SAT). Currently, few SAT providers accept Medicaid, and consequently, there is concern that newly-eligible Medicaid enrollees will have difficulty finding SAT providers willing to serve them. However, little is known about why few SAT providers accept Medicaid. In response, this study examines how features of state Medicaid coverage for SAT, including benefits, eligibility, and oversight, are associated with Medicaid acceptance among SAT providers. Medicaid acceptance was positively associated with the number of SAT services covered, and the number of optional categorical expansions implemented by the state. Requirements for physician involvement were associated with lower odds of acceptance. The results suggest that more generous Medicaid coverage may encourage SAT providers to accept Medicaid, but regulatory policies may inhibit their ability to do so.

Citing Articles

Harm Reduction and Treatment Among People at High Risk of Overdose.

Bandara S, Byrne L, Berman V, Hurst A, King D, Gibbons J JAMA Netw Open. 2024; 7(8):e2427241.

PMID: 39133486 PMC: 11320172. DOI: 10.1001/jamanetworkopen.2024.27241.


Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years.

Abraham A, Harris S, Yarbrough C J Subst Use Addict Treat. 2023; 158:209247.

PMID: 38072386 PMC: 10947910. DOI: 10.1016/j.josat.2023.209247.


Health Insurance and Mental Health Treatment Use Among Adults With Criminal Legal Involvement After Medicaid Expansion.

Howell B, Hawks L, Balasuriya L, Chang V, Wang E, Winkelman T Psychiatr Serv. 2023; 74(10):1019-1026.

PMID: 37016823 PMC: 10939137. DOI: 10.1176/appi.ps.20220171.


Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.

Abraham A, Yarbrough C, Harris S, Adams G, Andrews C Psychiatr Serv. 2020; 72(2):148-155.

PMID: 33267651 PMC: 8262068. DOI: 10.1176/appi.ps.202000049.


Medicaid Expansion and Low-Income Adults with Substance Use Disorders.

Olfson M, Wall M, Barry C, Mauro C, Feng T, Mojtabai R J Behav Health Serv Res. 2020; 48(3):477-486.

PMID: 33156464 PMC: 8099922. DOI: 10.1007/s11414-020-09738-w.


References
1.
McCarty D, Argeriou M . The Iowa Managed Substance Abuse Care Plan: access, utilization, and expenditures for Medicaid recipients. J Behav Health Serv Res. 2003; 30(1):18-25. DOI: 10.1007/BF02287810. View

2.
Fossett J, Peterson J . Physician supply and Medicaid participation. The causes of market failure. Med Care. 1989; 27(4):386-96. DOI: 10.1097/00005650-198904000-00006. View

3.
McLellan A, Carise D, Kleber H . Can the national addiction treatment infrastructure support the public's demand for quality care?. J Subst Abuse Treat. 2003; 25(2):117-21. View

4.
Zuckerman S, McFeeters J, Cunningham P, Nichols L . Changes in medicaid physician fees, 1998-2003: implications for physician participation. Health Aff (Millwood). 2004; Suppl Web Exclusives:W4-374-84. DOI: 10.1377/hlthaff.w4.374. View

5.
Berman S, Dolins J, Tang S, Yudkowsky B . Factors that influence the willingness of private primary care pediatricians to accept more Medicaid patients. Pediatrics. 2002; 110(2 Pt 1):239-48. DOI: 10.1542/peds.110.2.239. View